Clinical Trial Update: Relative Bioavailability Study Of Two Lincomycin Hydrochloride Hard Gelatinous Capsule [Phase 1]

View source ↗

Summary

Pfizer conducted a Phase 1 relative bioavailability study comparing two lincomycin hydrochloride hard gelatin capsules. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Infections

Drugs mentioned

• Lincomycin hydrochloride hard gelatin capsules (lincomycin hydrochloride)

Snippet

Sponsor: Pfizer | Conditions: Bacterial Infections | Phase 1 | Status: COMPLETED